DERM Bear Put Spread Strategy
DERM (Journey Medical Corporation), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
DERM (Journey Medical Corporation) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $141.9M, a beta of 1.04 versus the broader market, a 52-week range of 4.31-9.555, average daily share volume of 226K, a public-listing history dating back to 2021, approximately 41 full-time employees. These structural characteristics shape how DERM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.04 places DERM roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a bear put spread on DERM?
A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.
Current DERM snapshot
As of May 15, 2026, spot at $6.25, ATM IV 312.00%, IV rank 63.37%, expected move 89.45%. The bear put spread on DERM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this bear put spread structure on DERM specifically: DERM IV at 312.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 89.45% (roughly $5.59 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DERM expiries trade a higher absolute premium for lower per-day decay. Position sizing on DERM should anchor to the underlying notional of $6.25 per share and to the trader's directional view on DERM stock.
DERM bear put spread setup
The DERM bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DERM near $6.25, the first option leg uses a $6.25 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DERM chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DERM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $6.25 | N/A |
| Sell 1 | Put | $5.94 | N/A |
DERM bear put spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.
DERM bear put spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bear put spread on DERM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bear put spread on DERM
Bear put spreads on DERM reduce the cost of a bearish DERM stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
DERM thesis for this bear put spread
The market-implied 1-standard-deviation range for DERM extends from approximately $0.66 on the downside to $11.84 on the upside. A DERM bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on DERM, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current DERM IV rank near 63.37% is mid-range against its 1-year distribution, so the IV signal is neutral; the bear put spread thesis on DERM should anchor more to the directional view and the expected-move geometry. As a Healthcare name, DERM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DERM-specific events.
DERM bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DERM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DERM alongside the broader basket even when DERM-specific fundamentals are unchanged. Long-premium structures like a bear put spread on DERM are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current DERM chain quotes before placing a trade.
Frequently asked questions
- What is a bear put spread on DERM?
- A bear put spread on DERM is the bear put spread strategy applied to DERM (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With DERM stock trading near $6.25, the strikes shown on this page are snapped to the nearest listed DERM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DERM bear put spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the DERM bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 312.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DERM bear put spread?
- The breakeven for the DERM bear put spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DERM market-implied 1-standard-deviation expected move is approximately 89.45%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bear put spread on DERM?
- Bear put spreads on DERM reduce the cost of a bearish DERM stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
- How does current DERM implied volatility affect this bear put spread?
- DERM ATM IV is at 312.00% with IV rank near 63.37%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.